Japan approves use of Covid-19 antiviral treatment pill

Tokyo: In Japan, Government's regulatory panel has approved the use of COVID-19 antiviral treatment pill called Molnupiravir developed by Merck & Co Inc. National broadcaster NHK



reported that the approval was widely expected and opens the door to shipments of 200,000 doses across the country from this weekend.